Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lora Hedrick is active.

Publication


Featured researches published by Lora Hedrick.


The American Journal of Surgical Pathology | 1989

Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.

Lora Hedrick; Jonathan I. Epstein

The identification of basal cells is often helpful in excluding a diagnosis of prostate carcinoma. However, it can be difficult to distinguish basal cells from underlying fibroblasts or an artifactual two-cell layer in neoplastic glands. To determine the usefulness of anti-keratin antibody 903 for identifying basal cells in glandular patterns sometimes confused with carcinoma, we examined frozen sections from radical prostatectomy specimens and formalin-fixed needle biopsy, radical prostatectomy, and transurethral resection specimens. Atrophic glands, basal cell hyperplasia, intraductal severe dysplasia and various grades of carcinoma were examined. Also evaluated were cases of atypical adenosis, defined as clusters of small glands that mimic low-grade carcinoma yet focally appear to have a basal cell layer and merge with more recognizable benign glands. Almost all normal glands showed some staining, although it was often discontinuous with formalin fixation. Intraductal dysplasia stained in a manner similar to normal glands. Ninety-two percent of atrophic glands and 88% of glands in basal cell hyperplasia stained. Sixty-one percent of th& glands in atypical adenosis stained intensely but discontinuously. All grades of adenocarcinoma lacked any immunoreactivity. These results indicate that keratin 903 is useful in the diagnosis of prostatic carcinoma because positive staining identifies a questionable focus as benign whereas negative staining helps to substantiate the diagnosis of carcinoma.


Trends in Cell Biology | 1993

Cell adhesion molecules as tumour suppressors

Lora Hedrick; Kathleen R. Cho; Bert Vogelstein

Cell adhesion molecules, a diverse group of proteins expressed on the cell surface, have been implicated in numerous important cellular functions ranging from controlling morphogenesis to suppressing tumourigenesis. In this article, we discuss evidence supporting the idea that at least some proteins involved in cell adhesion may suppress tumourigenesis through influences on cell growth, differentiation and/or invasion. These studies suggest that some cell adhesion molecules may be encoded by tumour suppressor genes.


Cancer Genetics and Cytogenetics | 1996

Chromosome abnormalities in primary endometrioid ovarian carcinoma

Raluca Yonescu; John L. Currie; Lora Hedrick; Janice Campbell; Constance A. Griffin

Specific and recurrent chromosome abnormalities may occur in regions of the genome that are involved in the conversion of normal cells to those with tumorigenic potential. Ovarian cancer is the primary cause of death among patients with gynecologic malignancies. We performed cytogenetic analysis in a subgroup of epithelial ovarian tumors, the endometrioid tumors, which are histologically indistinguishable from endometrial carcinoma of the uterus. We studied 10 endometrioid tumors to determine the degree of cytogenetic similarity between these two carcinomas. Six of 10 endometrioid tumors showed a near-triploid modal number, and one had a tetraploid modal number. Eight of the 10 contained structural chromosome abnormalities, of which the most frequent were 1p-- (5 tumors), 6q-- (4 tumors), 19q+ (4 tumors), and chromosome 3 rearrangements (4 tumors). These cytogenetic results resemble those reported for papillary ovarian tumors and differ from those of endometrial carcinoma of the uterus. We conclude that despite the histologic similarities between the endometrioid and endometrial carcinomas, the genetic abnormalities in the genesis of these tumors differ significantly.


American Journal of Obstetrics and Gynecology | 1989

Abscess of allantoic duct remnant

I. Cori Baill; G. William Moore; Lora Hedrick

A recently submitted placenta was found to be histopathologically unique. Funicitis was present at the early gestational age of 22 1/7 weeks, and an abscessed allantoic duct remnant was present. The latter finding had not previously been seen at this pathology department, nor could reference to it be found in the literature.


Cancer Research | 1996

DPC4 Gene in Various Tumor Types

Mieke Schutte; Ralph H. Hruban; Lora Hedrick; Kathleen R. Cho; Gyongyi Molnar Nadasdy; Craig L. Weinstein; G. Steven Bova; William B. Isaacs; Paul Cairns; Homaira Nawroz; David Sidransky; Robert A. Casero; Paul S. Meltzer; Stephan A. Hahn; Scott E. Kern


Cancer Research | 1995

A Transforming Growth Factor β Receptor Type II Gene Mutation Common in Colon and Gastric but Rare in Endometrial Cancers with Microsatellite Instability

Lois Myeroff; Ramon Parsons; Seong-Jin Kim; Lora Hedrick; Kathleen R. Cho; Kim Orth; Michael Mathis; Kenneth W. Kinzler; James Lutterbaugh; Keunchil Park; Yung Jue Bang; Hwa Young Lee; Jae-Gahb Park; Henry T. Lynch; Anita B. Roberts; Bert Vogelstein; Sanford D. Markowitz


Proceedings of the National Academy of Sciences of the United States of America | 1993

Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

Theodore D. Kessis; Robbert J. Slebos; William G. Nelson; Michael B. Kastan; Beverly Plunkett; Sung M. Han; Attila T. Lorincz; Lora Hedrick; Kathleen R. Cho


Proceedings of the National Academy of Sciences of the United States of America | 1995

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Tzyy-Choou Wu; F. G. Guarnieri; Kevin Staveley-O'Carroll; R. P. Viscidi; H. I. Levitsky; Lora Hedrick; Kathleen R. Cho; J. T. August; D. M. Pardoll


American Journal of Pathology | 1997

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

Hironori Tashiro; Christina Isacson; Ross Levine; Robert J. Kurman; Kathleen R. Cho; Lora Hedrick


Proceedings of the National Academy of Sciences of the United States of America | 1994

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

Robbert J. Slebos; Myung-Ho Lee; Beverly Plunkett; Theodore D. Kessis; Bart O. Williams; Tyler Jacks; Lora Hedrick; Michael B. Kastan; Kathleen R. Cho

Collaboration


Dive into the Lora Hedrick's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bert Vogelstein

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Burks Rt

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge